Study guide

1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing

Certified Pulmonary Function Technologist CPFT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview & NBRC Certification Requirements

1.1 NBRC PFT Exam Logistics, Format, and Scoring Criteria 1.2 Scope of Practice, Candidate Admission Pathways, and Credential Maintenance 1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing

2 Chapter 2: Spirometry Equipment & Sensors

2.1 Volume-Displacement Spirometers: Water-Seal, Rolling-Seal, Bellows 2.2 Flow-Sensing Pneumotachometers: Fleisch, Lilly, Vortex, Turbine, Pitot Tube, Ultrasonic 2.3 Calibration Standards & 3-Liter Syringe Quality Control Verification

3 Chapter 3: Body Plethysmography & Hardware

3.1 Body Plethysmograph Principles: Pressure, Volume, and Variable-Pressure-Constant-Volume Design 3.2 Plethysmograph Calibration, Pressure Transducers, and Shutter Mechanics 3.3 Quality Control, Isothermal Corrections, and Leak Detection in Plethysmography

4 Chapter 4: Gas Analyzers, Environmental Sensors, & Infection Control

4.1 Rapid and Multi-Gas Analyzers: Infrared, Zirconium, Mass Spec, Electrochemical, Thermal Conductivity 4.2 Environmental Sensors, Barometric Pressure, Temperature, and BTPS Correction Factors 4.3 Infection Control, Equipment Decontamination, Disposable Filters, and Spaulding Classification 4.4 Monitors: Pulse Oximeters, Blood Pressure Devices, and ECG Equipment 4.5 Gas Delivery Systems, Valves, Absorbers, and Aerosol / Inhaler Devices

5 Chapter 5: Spirometry Protocols & ATS/ERS Criteria

5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols 5.2 ATS/ERS Spirometry Acceptability, Repeatability, and Usability Criteria 5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops

6 Chapter 6: Lung Volume Determination Protocols

6.1 Open-Circuit Nitrogen Washout Method: Principles, Equipment, and Calculation 6.2 Closed-Circuit Helium Dilution Method: Principles, Equipment, and Calculation 6.3 Thoracic Gas Volume (TGV/FRCpleth) and Comparison of Lung Volume Methods

7 Chapter 7: Diffusing Capacity & Bronchial Challenge Testing

7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol 7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA 7.3 Bronchial Provocation Testing: Methacholine Challenge, Exercise-Induced Bronchospasm, and EIB Protocols 7.4 Inhaled Medication Delivery Technique and Patient Education

8 Chapter 8: Cardiopulmonary Exercise & ABG Testing

8.1 Cardiopulmonary Exercise Testing (CPET) Protocols, VO2max, and Anaerobic Threshold 8.2 Six-Minute Walk Test (6MWT) Protocol, Desaturation Monitoring, and O2 Titration 8.3 Arterial Blood Gas (ABG) Sampling, Allen Test, Analyzer Maintenance, and Quality Control 8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data 8.5 CO-Oximetry / Hemoximetry: Measurement, Dyshemoglobins, and Clinical Implications 8.6 Exercise Monitoring Data: Blood Pressure Response and ECG Rhythm Analysis

9 Chapter 9: Reference Values & PFT Calculations

9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards 9.2 BTPS, STPD, and ATPS Conversion Formulas and Calculations 9.3 Gas Exchange Formulas, Alveolar Air Equation, and Mechanical Calculations

10 Chapter 10: Pattern Recognition & Clinical PFT Interpretation

10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis 10.2 Restrictive Ventilatory Defects: Parenchymal, Chest Wall, and Neuromuscular Disorders 10.3 Mixed Ventilatory Defects, Isolated Diffusion Defects, and Reversibility Protocols

11 Chapter 11: Artifact Recognition & Quality Assurance

11.1 Spirometry Artifacts: Hesitation, Coughing, Early Termination, Glottic Closure, Leak 11.2 Lung Volume and DLCO Artifacts: Panting Frequency, Shutter Leaks, Breath-Hold Failure 11.3 Quality Control Charts, Westgard Rules, and Laboratory Quality Assurance

12 Chapter 12: Documentation, Compliance, & Emergency Safety

12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics 12.2 CPT Billing Codes, ICD-10 Coding, HIPAA Privacy, and EHR Compliance 12.3 Emergency Preparedness, Contraindications, and Patient Safety Management in PFT Lab

13 Chapter 13: Specialized Procedures, Home Testing & Longitudinal Data

13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow 13.2 Sputum Sample Collection: Spontaneous and Induced Specimens 13.3 Home Testing Instruction: Home Spirometry, Peak Flow Diaries, and Home Oximetry 13.4 Pediatric Pulmonary Function Testing and Upright Versus Supine Spirometry 13.5 Serial Pulmonary Function Testing, Clinical History, Demographics, and Laboratory Quality Management

1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing

Key Takeaways Explain This Topic AI

The NBRC Code of Conduct establishes enforceable ethical standards regarding honesty, professional integrity, patient privacy, and clinical competence.

Under ATS/ERS 2019 there are no absolute contraindications to spirometry; all listed conditions are relative, and the ordering clinician makes the risk-benefit decision.

The 2019 update shortened key timeframes: acute myocardial infarction within 1 week, eye surgery within 1 week, sinus or middle ear surgery/infection within 1 week, and brain, thoracic, or abdominal surgery within 4 weeks.

Patient safety protocols mandate immediate access to emergency resuscitation equipment, oxygen, and bronchodilators during maximal diagnostic maneuvers.

Infection control standards mandate single-use inline bacterial/viral filters, routine disassembly/disinfection of reusable components, and strict hand hygiene between patients.

Last updated: August 2026

1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing

Pulmonary function testing requires technologists to perform strenuous, maximal diagnostic maneuvers on vulnerable patients who may present with severe cardiopulmonary impairment. Consequently, adherence to strict professional ethics, rigorous pre-test patient screening, robust emergency safety protocols, stringent infection control, and patient privacy regulations is essential to prevent adverse clinical events and maintain public trust.

NBRC Code of Ethics and Judicial Committee Enforcement

All CPFT credential holders and examination candidates are bound by the NBRC Code of Conduct . This ethical framework establishes mandatory principles governing professional practice, patient interactions, and data integrity.

Enforceable Ethical Principles

Integrity of Diagnostic Data: Technologists must record and report pulmonary diagnostic data truthfully, accurately, and without falsification or selective omission. Modifying calibration factors to force failing tests into "acceptable" ranges constitutes severe ethical misconduct.

Maintenance of Competence: Technologists must maintain clinical and technical currency, refusing to perform complex diagnostic procedures (e.g., methacholine challenge or arterial line placement) unless properly trained and qualified.

Patient Advocacy & Respect: Technologists must treat all patients with dignity, avoiding discrimination based on race, age, gender, religion, national origin, or disability status.

Avoidance of Conflicts of Interest: Technologists must decline financial kickbacks, unauthorized equipment endorsements, or unapproved referral fees that compromise objective clinical judgment.

Role of the NBRC Judicial Committee

The NBRC Judicial Committee is empowered to investigate allegations of ethical misconduct, examination subversion, credential fraud, substance abuse impairment, and state licensing disciplinary actions.

  • Disciplinary Action Description & Consequences
  • Reprimand Formal written censure issued for minor or initial ethical infractions
  • Suspension Temporary revocation of CPFT credential rights for a specified duration
  • Revocation Permanent cancellation of NBRC credentials; prohibition from future examination
  • Pre-Test Patient Screening & Contraindication Assessment

Before initiating forced exhalation maneuvers, plethysmographic body box testing, or exercise stress testing, the technologist must conduct a comprehensive pre-test screening to identify contraindications that present unacceptable patient risks.

The 2019 ATS/ERS Contraindication Framework

Forced expiratory maneuvers raise intrathoracic, intra-abdominal, intracranial, intraocular, and sinus/middle-ear pressures, increase myocardial demand, and swing systemic blood pressure. The 2019 ATS/ERS Standardization of Spirometry made a change that older textbooks have not caught up with: there are no absolute contraindications to spirometry. Every listed condition is a relative contraindication. Spirometry is not precluded; the ordering clinician performs a risk–benefit assessment for that specific patient, and potential contraindications should be flagged on the request form so the technologist knows what to watch for. Testing stops immediately if the patient experiences pain during the maneuver.

The 2019 statement also shortened several timeframes. The pre-2019 "no testing within one month of a myocardial infarction" rule became within one week . +-----------------------------------------------------------------------------------+

  • | RELATIVE CONTRAINDICATIONS TO SPIROMETRY (ATS/ERS 2019) - GROUPED BY RISK |
  • +-----------------------------------------------------------------------------------+
  • | INCREASED MYOCARDIAL DEMAND OR BLOOD PRESSURE CHANGE |
  • | - Acute myocardial infarction within 1 WEEK |
  • | - Systemic hypotension or severe hypertension |
  • | - Significant atrial or ventricular arrhythmia |
  • | - Noncompensated heart failure |
  • | - Uncontrolled pulmonary hypertension; acute cor pulmonale |
  • | - Clinically unstable pulmonary embolism |
  • | - History of syncope related to forced expiration or cough |
  • +-----------------------------------------------------------------------------------+
  • | INCREASED INTRACRANIAL / INTRAOCULAR PRESSURE |
  • | - Cerebral aneurysm |
  • | - Brain surgery within 4 WEEKS |
  • | - Recent concussion with continuing symptoms |
  • | - Eye surgery within 1 WEEK |
  • +-----------------------------------------------------------------------------------+
  • | INCREASED SINUS / MIDDLE EAR PRESSURE |
  • | - Sinus surgery, middle ear surgery, or middle ear infection within 1 WEEK |
  • +-----------------------------------------------------------------------------------+
  • | INCREASED INTRATHORACIC / INTRA-ABDOMINAL PRESSURE |
  • | - Presence of pneumothorax |
  • | - Thoracic surgery within 4 WEEKS |
  • | - Abdominal surgery within 4 WEEKS |
  • | - Late-term pregnancy |
  • +-----------------------------------------------------------------------------------+
  • | INFECTION CONTROL |
  • | - Active or suspected transmissible respiratory or systemic infection, |
  • | including tuberculosis |
  • | - Physical conditions predisposing to transmission (e.g., hemoptysis, open |
  • | oral sores, significant secretions) |
  • +-----------------------------------------------------------------------------------+

Exam nuance: Aortic aneurysm was historically listed as a contraindication. The 2019 task force reviewed the limited available data (no adverse events reported in abdominal aneurysms 5–13 cm or thoracic aneurysms 5–8 cm) and did not retain it as a listed relative contraindication. Conditions that merely prevent a valid effort — nausea, vomiting, oral or facial pain, confusion or dementia, stress incontinence — are not safety contraindications but are documented reasons a session may yield unusable data.

Pre-Test Instruction & Medication Withholding

To obtain accurate baseline diagnostic data and evaluate bronchodilator responsiveness, technologists must verify that patients have adhered to medication withholding guidelines prior to testing:

  • Medication Class Examples ATS/ERS 2019 Withhold Time
  • SABA Albuterol (salbutamol), levalbuterol 4–6 hours
  • SAMA Ipratropium bromide 12 hours
  • LABA Formoterol, salmeterol 24 hours
  • Ultra-LABA Indacaterol, vilanterol, olodaterol 36 hours
  • LAMA Tiotropium, umeclidinium, aclidinium, glycopyrronium 36–48 hours

Smoking / vaping: no smoking within 1 hour of spirometry, and avoid smoking on the day of a DLCO study (24 hours is the practical target) because carboxyhemoglobin back-pressure falsely lowers DLCO.

Judgment call: if the clinical question is whether lung function can be improved beyond the patient's current regimen, ATS/ERS allows the patient to continue their usual medication — adherence should be checked first and the medication status documented on the report.

Patient Safety Protocols & Emergency Preparedness

Because maximal forced exhalation and bronchial challenge testing carry inherent risks of syncope, severe bronchospasm, and dysrhythmias, pulmonary laboratories must maintain strict emergency preparedness:

Managing Syncope & Vasovagal Events:

Forced exhalation causes decreased venous return to the heart due to sustained high intrathoracic pressure (Valsalva effect), leading to cerebral hypoperfusion and cough syncope.

Safety Rule: Patients MUST be seated in a secure chair with armrests (wheelchair locked) during all testing. Technologists must never perform spirometry on a standing patient.

Emergency Resuscitation Availability:

The PFT laboratory must have immediate access to a fully equipped emergency crash cart, supplemental oxygen, high-flow suction, bag-valve-mask (BVM) resuscitators, an automated external defibrillator (AED), and emergency bronchodilator / anaphylaxis medications (Albuterol, Epinephrine).

Continuous Monitoring During Strenuous Testing:

During cardiopulmonary exercise testing (CPET) and bronchial challenge testing, continuous 12-lead ECG, pulse oximetry (SpO2), and non-invasive blood pressure (NIBP) monitoring are mandatory.

Infection Control & Decontamination Standards

Pulmonary diagnostic procedures produce significant high-velocity aerosols and droplet nuclei during coughing and forced exhalation, creating substantial cross-contamination hazards.

Infection Control Hierarchy

Single-Use Inline Bacterial/Viral Filters: Every patient MUST be tested using a dedicated, single-use, high-efficiency bacterial/viral filter placed between the patient's mouth and the flow sensor/tubing. Filters must demonstrate > 99.9% filtration efficiency for both bacteria and viruses.

Spaulding Classification for Equipment Disinfection:

Semi-Critical Items: Reusable equipment contacting intact mucous membranes (e.g., non-disposable pneumotachometers, reusable mouthpieces, nose clips, body box interior handles) requires high-level disinfection (HLD) using EPA-registered liquid chemical sterilants (e.g., glutaraldehyde, peracetic acid, or hydrogen peroxide plasma) between patients.

Non-Critical Items: External equipment surfaces, computer keyboards, and outer plethysmograph walls require intermediate-level disinfection with hospital-grade germicidal wipes.

Hand Hygiene: Strict hand hygiene (alcohol-based hand rub or soap and water washing for > 20 seconds) must be performed immediately before putting on gloves and after glove removal between every patient.

Patient Confidentiality & HIPAA Compliance

Diagnostic pulmonary software systems generate extensive electronic Protected Health Information (ePHI). Technologists must adhere strictly to Health Insurance Portability and Accountability Act (HIPAA) mandates:

Data Security: Computerized PFT workstations must utilize automatic screen lock timeouts, role-based access control, and encrypted storage for patient database records.

Secure Transmission: Transmitting diagnostic reports over public networks requires end-to-end encryption.

Informed Consent: Prior to testing, technologists must explain the procedure, potential risks, and diagnostic benefits to the patient, obtaining verbal or written informed consent.